Head and Neck Cancer Clinical Trials in Novara
2 recruitingNovara, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE350 enrolled189 locationsNCT04534205
Recruiting
DOsimetry and Radiation Induced NAusea in Head and Neck Cancers
Head and Neck Cancer
European Institute of Oncology180 enrolled14 locationsNCT06341985